Navigation Links
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Date:7/29/2009

products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.

    Contact: Company                             Contact: Investor Relations
    Stephen B. Thompson,         Donald C. Weinberger/ Diana Bittner (media)
    Vice President,                      Wolfe Axelrod Weinberger Assoc. LLC
    Chief Financial Officer                                   (212) 370-4500
    Access Pharmaceuticals, Inc.,
    (214)  905-5100


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. The State of Louisiana and Together Rx Access Join Forces to Improve Prescription Access for Uninsured Residents
2. Fingertip Formulary Accounts(R) Now Offers Access to Comprehensive Real-Time Account Information and Integrated Formulary Data, in a State-of-the Art Web-Based Platform
3. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
4. Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser-Therapy.US
5. Accuray Announces CyberKnife Access Remote Service Product
6. President Obama Announces Intention to Sign United Nations Convention on the Rights of Persons with Disabilities, Impacts Accessible ICT
7. Cost-Conscious Texans Find Relief with Direct Access Lab Testing
8. UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
9. Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
10. Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock Conference
11. Carefx Implements Fusionfx at Fletcher Allen Health Care to Improve Anywhere/Anytime Access to Crucial Patient Information

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--Whenmostpeoplehearth...orcanalsogivepatientsthehelptheyneed.TMJstandsfort...dible)contacts/connectswithyourskull(temporalbone)...unctionarepainwithchewing,clickingorpoppingoftheja...nincluding:headaches,fatigue,sleepdisturbances,irr...
(Date:11/25/2009)...lif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceu...panywillhosttwoinvestoreventsinDecember: ,, A...00a.m.ET ,, Principalinvestigatorswilldiscuss...nd/orrefractorymultiplemyeloma,asfeaturedatthe51st...positioninNewOrleans,LA.Theteleconferencewillbegin...
(Date:11/25/2009)...5/PRNewswire/-SentinelleMedicalInc.,aleadingmanufa...warelaunchesasuiteofnewleadingedgeclinicalapplicat...thisyear,sRadiologicalSocietyofNorthAmerica(RSNA)a...HallA).Theapplicationsleveragetheuniquehighquality...coilsandsupportmultipleimagingmodalitiesformulti-p...
(Date:11/25/2009)...Md.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJane...uationandResearch,titled"ADifficultBalance-PainMan...009issueofTheNewEnglandJournalofMedicine. ,, (L...FDALOGO ) ,, Inthearticle,WoodcockdiscussesFDAe...nforthosewhoneeditandmanagingtherisksposedbyvariou...
(Date:11/25/2009)...Nov.25/PRNewswire/--TheBayAreaAirQualityManagement... the Air Alert forThursday,November26,20...hersolidfuel,bothindoorsandoutdoors. ,, "Cold,s...rrow,"saidJackBroadbent,executiveofficeroftheAirDi...lthoftheirneighborsandfellowcommunitymembersthisTh...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...e University of Michigan Health System say the fed...he elderly in a cost-effective manner that would u...eral government were to start a Flu vaccination pr...o are at a higher risk of death due to influenza v...
...sed by researchers at Medical College of Wisconsin... the improvement in survival rate in cardiac arres...study would be funded by the National Heart, Lung,...arrest and severe traumatic injury, and would be s...
...ical major Ranbaxy Laboratories Limited Friday ann...for asthma patients//. "Ranbaxy has introduce...e is available in HFA (Hydroxy fluoro Alkane: the ...de HFA Inhaler, as opposed to the conventional CFC...
...d Health Organization (WHO), two fresh cases of po...another from Mudug region//, in southern Somalia a...s, with security-related restrictions, present a r... a total of 199 children to date, but which appear...
...study conducted by Theodore Blaine, M.D., assistan...versity Medical Center and an attending// surgeon ...te, a drug that is FDA-approved for osteoarthritis...ox-2 inhibitors. After that people went for surger...
...r of drug resistance TB is becoming apparent to th...t time. The Union Ministry is now pulling up// its...resistant MDR-TB. DOTS Plus, or directly obs... Maharashtra and Gujarat. 100 MDR-TB cases are env...
Other Medicine News:Health News:Influenza Vaccination For The Elderly 2Health News:An Effective Drug Identified for Shoulder Pain 2
(Date:11/25/2009)...5/PRNewswire/--Reportlinker.comannouncesthatanewma... IntranasalDrugDelivery-USMarketTrends&Analys...l-Drug-Delivery---US-Market-Trends--Analysis.html ...nganexpansionoftherapeuticapplicationsfromthedeliv...yofsystemictherapeuticdrugs.Thefutureofthetechnolo...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--ChindexInternational,Inc....ricanproviderofWestern,healthcareproductsandservic...theCompanywillattendthe21stAnnualPiperJaffray,"Unp...09,atthe,NewYorkPalaceHotel. , Managementiscu...ember1,2009,andholdone-on-onemeetingsthroughoutthe...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VR...anofReorganizationandDisclosureStatementtoday,Nove...heDistrictofDelaware.Ahearingtoconsiderapprovaloft...er8,2009,withthehearingontheconfirmationofthePlans...Companytopayallclaimsinfull.ThePlanisexpected,ifap...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Music is the engine of new U M lab on a chip device 9321 1Music is the engine of new U M lab on a chip device 9321 2Stunting plants skyward reach could lead to improved yields 9318 1Stunting plants skyward reach could lead to improved yields 9318 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 1Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 3Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 4
...ns for treating returning vets and others exposed ... Schepens Eye Research Institute have shown for th...ause both eyes to lose a special protective abilit...ects the eye without the inflammation of the body,... delicate eye tissue. This finding, published in t...
...ExonHit Therapeutics,(Alternext: ALEHT) is pleased... lead compound in Alzheimer,s disease, is progress...l assessing EHT 0202 in patients with,Alzheimer,s ...tion of patient enrolment for the Phase IIa,repres...EHT 0202, and,provides a clear timeline for the re...
Other Medicine Technology:Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4
Naked Gold 20 nm
Naked Gold 20 nm - 50 OD
CranioFix2 Titanium Clamp System
...ate, reliable, portable, and easy-to-use pachymete... a dual-rechargeable battery system that makes cha...lution, color, touch screen controls make operatin...ent software simplifies calculating adjustments to...
Medicine Products: